This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Iouri Tikhosovich Kalinin: Innovator in Glucose Management
Introduction
Iouri Tikhosovich Kalinin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biomedical engineering, particularly in the area of glucose management. His innovative work focuses on developing effective means for maintaining and correcting glucose concentrations in the blood.
Latest Patents
Kalinin holds a patent for a groundbreaking invention titled "Means for maintenance and/or correction of glucose concentration in blood." This invention relates to preparations that are useful in maintaining mammalian blood glucose concentrations. The preparations contain insulin and a polymeric matrix, which features a core of biodegradable, hydrophobic polymer and an outer shell of a biodegradable, hydrophobic polymer. This innovative formulation aims to enhance the management of blood glucose levels in individuals.
Career Highlights
Throughout his career, Kalinin has demonstrated a commitment to advancing medical technology. His work has been recognized for its potential impact on diabetes management and overall health. With a focus on practical applications, he continues to explore new avenues for improving patient care through innovative solutions.
Collaborations
Kalinin has collaborated with esteemed colleagues in his field, including Gennadiy Ljvovich Khromov and Boris Ivanovich Leoniv. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work.
Conclusion
Iouri Tikhosovich Kalinin's contributions to glucose management through his innovative patent highlight his role as a key figure in biomedical engineering. His dedication to improving health outcomes through technology is commendable and reflects the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile